(Q39570489)

13 September 2017

1 reference

title

Ageing, serotonin and ketanserin (English)

1 reference

13 September 2017

Breckenridge A

1

1 reference

13 September 2017

publication date

1 January 1988

1 reference

13 September 2017

1 reference

13 September 2017

volume

36 Suppl 1

1 reference

13 September 2017

page(s)

44-54

1 reference

Receptors for 5-hydroxytryptamine on the sympathetic nerves of the rabbit heart

13 September 2017

cites work

1 reference

12 December 2020

The acute antihypertensive effect of ketanserin increases with age.

1 reference

12 December 2020

Antihypertensive mode of action of ketanserin

1 reference

12 December 2020

Decreased uptake of 3H-serotonin and endogenous content of serotonin in blood platelets in hypertensive patients

1 reference

12 December 2020

3Hserotonin uptake in human blood platelets is reduced by ouabain and endogenous digitalis-like inhibitors of Na+,K+-ATPase

1 reference

12 December 2020

Enhanced in vivo platelet "release reaction" in old healthy individuals

1 reference

12 December 2020

Serotonin and the vascular system. Role in health and disease, and implications for therapy

1 reference

12 December 2020

Three distinct subtypes of serotonergic receptors mediate the triphasic blood pressure response to serotonin in rats

1 reference

12 December 2020

Platelets in human essential hypertension: in vitro hyperreactivity to thrombin

1 reference

12 December 2020

A comparative and long-term evaluation of ketanserin in the treatment of essential hypertension

1 reference

12 December 2020

Randomised trial of treatment of hypertension in elderly patients in primary care

1 reference

12 December 2020

Ketanserin--a new antihypertensive agent

1 reference

12 December 2020

Decreased Beta-adrenoreceptor responsiveness as related to age, blood pressure, and plasma catecholamines in patients with essential hypertension

1 reference

12 December 2020

Serotonin and preactivated platelets in essential hypertension

1 reference

12 December 2020

Antihypertensive efficacy of ketanserin alone or in combination with a beta-blocker or a diuretic: the Swiss Ketanserin Study

1 reference

12 December 2020

Blood pressure reduction and pharmacokinetics of ketanserin in hypertensive patients

1 reference

12 December 2020

Ketanserin: a new hypotensive drug?

1 reference

12 December 2020

Renin profiling to select antihypertensive baseline drugs. Renin inhibitors for high-renin and calcium entry blockers for low-renin patients

1 reference

12 December 2020

Efficacy of antihypertensive drug treatment according to age, sex, blood pressure, and previous cardiovascular disease in patients over the age of 60

1 reference

12 December 2020

Does acute serotonergic type-2 antagonism reduce blood pressure? Comparative effects of single doses of ritanserin and ketanserin in essential hypertension.

1 reference

12 December 2020

Ketanserin in essential hypertension: use as monotherapy and in combination with a diuretic or beta-adrenoceptor antagonist

1 reference

12 December 2020

Cardiovascular effects of serotonin.

1 reference

12 December 2020

Endothelium-dependent responses to platelets and serotonin in spontaneously hypertensive rats

1 reference

12 December 2020

The central vasomotor effects of 5-hydroxytryptamie

1 reference

12 December 2020

Crystalline Serotonin

1 reference

12 December 2020

Plasma concentrations of platelet-specific proteins correlated with platelet survival

1 reference

12 December 2020

10.2165/00003495-198800361-00008

Identifiers

DOI

0 references

1 reference